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INTRODUCTION
Patients with end-stage renal disease (ESRD) are accompa-
nied by hypertension, increased volume, hyperparathyroid-
ism,1,2 and even uremia, all of which result in higher left ventric-
ular (LV) filling pressure, abnormal myocardial relaxation, 
thickened LV due to fibrosis,3 and ultimately diastolic dysfunc-
tion. Diastolic dysfunction, assessed using echocardiography, 
is associated with a marked increase in all-cause mortality in 
population-based studies, especially in patients with ESRD, 
because these patients are exposed to hemodynamic over-
load from excessive volume and pressure, anemia, arteriove-
nous shunts, and arterial remodeling.3-5
Renal transplantation is the treatment of choice for ESRD. 
Its impact on restoration of organ function makes it a promis-
ing treatment modality for patients with ESRD, not only for 
the renal system, but also for the cardiovascular system. Previ-
ous studies evaluating the effect of renal transplantation on 
the cardiovascular system have shown the resolution of LV hy-
The Impact of Perioperative Factors on Changes 
in Diastolic Function after Kidney Transplantation: 
A Retrospective Analysis
Eun Jung Kim1,2, Bon-Nyeo Koo1,2, So Yeon Kim1,2, Kyu Ha Huh3, Soojeong Kang1, and Yong Seon Choi1,2
Departments of 1Anesthesiology and Pain Medicine and 3Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, 
Seoul;
2Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Purpose: Cardiac changes in end-stage renal disease are the most common causes of death after kidney transplantation (KT). 
Chronic kidney disease presents a major risk factor for the development and progression of diastolic dysfunction. The purpose of 
this study was to identify the association between changes in left ventricular (LV) diastolic function and perioperative clinical fac-
tors in patients with preserved ejection fraction following KT.
Materials and Methods: We reviewed 115 patients who underwent KT between January 2011 and December 2015 with both pre- 
and post-transplant echocardiograms; patients with LV systolic dysfunction were excluded. LV diastolic function was measured 
using the ratio of early transmitral flow velocity to early diastolic velocity of the mitral annulus (E/e’).
Results: Patients with normal pre-operative LV systolic function (n=97) showed improvement in E/e’ after KT (11.9±4.4 to 
10.5±3.8, p=0.023). Additionally, post-KT estimated glomerular filtration ratio was associated with changes in E/e’ (odds ratio, 
-0.056; 95% confidence interval, -0.014 to -0.007; p=0.026). Among patients with preexisting diastolic dysfunction (20/97 patients), 
the amount of intraoperative fluid administration was related to E/e’ changes (odds ratio, 0.003; 95% confidence interval, 0.000 to 
0.005; p=0.029). 
Conclusion: KT is associated with improved diastolic function. Post-KT renal function was significantly related to changes in LV 
diastolic function. The amount of intraoperative fluid was a risk factor for worsening diastolic function after KT in patients with 
preexisting diastolic dysfunction.
Key Words:  Kidney transplantation, end-stage renal disease (ESRD), diastolic function
Original Article 
pISSN: 0513-5796 · eISSN: 1976-2437
Received: July 16, 2018   Revised: December 3, 2018
Accepted: January 3, 2019
Corresponding author: Yong Seon Choi, MD, PhD, Department of Anesthesiolo-
gy and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University 
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
Tel: 82-2-2228-2412, Fax: 82-2-2227-7897, E-mail: YSCHOI@yuhs.ac
•The authors have no potential conflicts of interest to disclose.
© Copyright: Yonsei University College of Medicine 2019
This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution Non-Commercial License (https://creativecommons.org/licenses/
by-nc/4.0) which permits unrestricted non-commercial use, distribution, and repro-
duction in any medium, provided the original work is properly cited.
Yonsei Med J 2019 Mar;60(3):291-297
https://doi.org/10.3349/ymj.2019.60.3.291
292
Diastolic Function after KT
https://doi.org/10.3349/ymj.2019.60.3.291
pertrophy and systolic dysfunction after transplantation; how-
ever, the impact on diastolic dysfunction was less significant, 
as dysfunction may persist or even worsen after transplanta-
tion.5-8 Since patients with ESRD undergoing renal transplan-
tation are subject to hemodynamic changes during the periop-
erative period, proper perioperative management in relation 
to diastolic function needs to be emphasized. Comprehensive 
perioperative management, accounting for changes in such 
parameters, would assist with an ideal management strategy 
for groups of patients who are vulnerable to diastolic dysfunc-
tion, such as patients with ESRD undergoing kidney transplan-
tation (KT). 
The ratio of LV transmitral early peak velocity to early dia-
stolic mitral annulus velocity (E/e’), measured using trans-
thoracic echocardiography (TTE), is the most reliable non-in-
vasive predictor of elevated LV filling pressure in ESRD.9 
Moreover, E/e’ ratio is a strong predictor of major adverse car-
diovascular events, other than ejection fraction (EF), in patients 
with ESRD.10,11 Previous studies have shown that perioperative 
conditions may be associated with cardiac alterations after re-
nal transplantation due to dynamic changes in intravascular 
volume and metabolic imbalance.6,12 The purpose of this study 
was to determine the perioperative clinical and laboratory fac-
tors that may be associated with changes in diastolic function, 
in terms of E/e’ ratio, among patients with ESRD receiving KT. 
MATERIALS AND METHODS
Study design
This study was a single-center retrospective analysis of a con-
secutive cohort of adult patients with ESRD who underwent 
KT between January 2011 and December 2015 and had pre- 
and post-transplant TTEs. All transplant recipients were gen-
erally administered the standard immunosuppressive protocol, 
which included induction therapy (anti-interleukin-2 receptor 
antibody), calcineurin inhibitor, mycophenolate, and steroid. 
Tapering of steroids was performed with the intent to transi-
tion into a steroid-free regimen after the first year if no former 
rejection episodes had occurred. Patients without pre- and/or 
post-transplant TTE and those who did not have adequate 
medical records regarding surgery and anesthesia were exclud-
ed. In addition, patients with LV systolic dysfunction (EF <52% 
for males and <54% for females) were excluded. This study’s 
procedures were approved by and conducted in accordance 
with the ethical standards of the Yonsei University Health Sys-
tem Institutional Review Board (IRB no. 4-2017-0104). The 
participant informed consent requirement was waived by the 
ethics committee due to the study’s retrospective design. 
Data collection 
Demographic, clinical, echocardiographic, and laboratory 
data were obtained directly from patient electronic medical re-
cords. Baseline patient demographic information, including 
the duration of ESRD and dialysis, types of dialysis, and un-
derlying medical comorbidities, were obtained from individu-
al patient interviews performed in the outpatient clinic prior 
to surgery. The underlying conditions related to renal failure 
(e.g., glomerulonephritis, diabetes, hypertension, and poly-
cystic kidney disease) were attained from pathologic confir-
mation. Intraoperative hemodynamic variables, including 
heart rate and blood pressure, were collected from the elec-
tronic anesthetic records. Information on intraoperative fluid 
balance, including estimated blood loss, urine output, fluid 
consumption, red blood cell concentration, and fresh frozen 
plasma, was also collected from the anesthetic records. The 
amount of fluid administered, estimated blood loss, and urine 
output during the post-operative period were collected from 
the vital sign records in the electronic medical record. The esti-
mated glomerular filtration rate (eGFR) was calculated using 
the Modification of Diet in Renal Disease equation.13 Anemia 
was defined as hemoglobin (Hb) <13 g/dL in males and <12 
g/dL in females, according to the Kidney Disease: Improving 
Global Outcomes (KDIGO) guidelines for patients with chron-
ic kidney disease.14 
Echocardiography and Doppler measurements
Pre-transplantation TTE was performed on the day after each pa-
tient’s regular hemodialysis schedule, while the post-trans-
plantation data were obtained from the TTE taken most re-
cently after surgery. Echocardiography was performed by ex-
perienced physicians from the echocardiography laboratory 
of the Cardiology Department at Severance Hospital in South 
Korea. Comprehensive TTE was performed using commer-
cially available equipment. Cardiac dimensions were acquired 
using M-Mode echocardiography or directly from two-dimen-
sional images. Left ventricular ejection fraction (LVEF), an in-
dicator of LV systolic function, was calculated using a modi-
fied biplane Simpson’s method from the apical two-chamber 
and four-chamber views. Transmitral Doppler inflow at the 
tips of the mitral leaflets was measured to obtain E-wave ve-
locity, E-wave deceleration time, A-wave velocity, and E/A ra-
tio. Average peak early diastolic velocity (e’) was obtained from 
the septal and lateral sides of the mitral annulus in the apical 
four-chamber view with proper pulsed-wave tissue Doppler 
imaging (TDI) settings. The ratio of LV early diastolic filling ve-
locity to the peak diastolic velocity of mitral medial annulus (E/
e’), measured using TTE, was calculated and used as an index 
of LV diastolic function and LV filling pressures.10,15,16 Refer-
ence values for echocardiographic parameters were defined 
according to the American Society of Echocardiography and 
European Association of Cardiovascular Imaging guidelines17,18 
as four recommended variables and their abnormal cut-off val-
ues as follows: annular e’ velocity (septal e’ <7 cm/sec, lateral 
e’ <10 cm/sec); average E/e’ ratio >14; left atrial (LA) maxi-
mum volume index >34 mL/m2; and peak tricuspid regurgi-
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tant velocity >2.8 m/sec. 
Statistical analysis
Continuous data are expressed as a mean±standard deviation 
or median (interquartile range), depending on the distribu-
tion of data, and categorical data are expressed as a number 
(%). Accordingly, paired t-test or Wilcoxon test was used for 
comparisons of paired observations. Categorical variables were 
compared using chi-squared tests. Linear regression analysis 
was used to analyze associations between clinical variables 
and changes in E/e’. Statistical analyses were performed using 
SPSS v23.0 (IBM Corporation, Armonk, NY, USA) software; p< 
0.050 was considered statistically significant. 
RESULTS
Of 516 adult patients who underwent KT between January 2011 
and December 2015, we identified 115 patients who fulfilled 
the inclusion and exclusion criteria (Fig. 1). Eighteen patients 
were excluded from the study due to insufficient pre- or post-
operative TTE data (n=10) and impaired baseline LV systolic 
function (n=8), resulting in 97 patients that were analyzed in 
this study. 
The baseline patient characteristics are shown in Table 1. 
The mean age was 49.5±10.6 y, and 71 (62%) patients were male. 
The etiology of ESRD was not defined in most patients (36%), 
followed by hypertension (26%) and diabetes mellitus (15%). 
The majority of the patients was dialysis-dependent: 94 (82%) 
patients were treated with hemodialysis and 15 (13%) patients 
with peritoneal dialysis. The median duration of dialysis was 4 
months (1–24 months). Hypertensive and heart failure pa-
tients were taking a range of antihypertensive medications, in-
cluding calcium channel blockers (63%), beta-blockers (47%), 
angiotensin-converting enzyme inhibitors or angiotensin II 
receptor blockers (58%), and diuretics (26%). 
The changes in structural TTE parameters and clinical and 
laboratory variables in the post-transplantation period are 
shown in Table 2. Of note, none of the patients underwent cor-
onary re-vascularization or cardiac re-synchronization thera-
py. Statistically significant improvements were observed in 
LVEF, LV mass/body surface area, LV end-diastolic diameter, 
LA volume index (LAVI), and E/e’ ratio. The mean E/e’ ratio 
significantly decreased after KT in patients with any degree of 
diastolic function (n=97; p=0.023) and in those with underly-
ing diastolic dysfunction (n=20; p<0.001). The average time in-
terval between KT and the follow-up TTE examination was 22.4 
months, while the TTE had been done earlier in those with 
underlying diastolic dysfunction (average time interval of 18.9 
months with earliest examination done at postoperative day 1). 
The degrees of Hb increment after surgery were 1.1 g/dL 
and 1.3 g/dL (p<0.001 for both) in all patients and in those 
with baseline anemia, respectively. Additionally, eGFR signifi-
cantly improved during the post-operative follow-up period 
(Table 2). 
Univariate analysis indicated that restoration of renal func-
tion, according to the increment of eGFR at post-operative 
day 7 and at 1 year post-operation, was significantly associat-
Table 1. Baseline Patient Characteristics
Pre- and Post- 
transplant TTE 
(n=115)
Pre-transplant 
TTE (n=396)
No TTE 
(n=5)
Transplant age (yr) 49.5±10.6 44.9±11.4* 49.2±6.9
Male 71 (62) 195 (49) 3 (60)
Body mass index (kg/m2) 23.2±3.1 22.3±3.0* 21.1±1.8
Body surface area (m2) 1.69±0.16 1.67±0.18 1.61±0.11
Renal condition
Diabetes mellitus 17 (15) 12 (3)* 2 (40)†,‡
Hypertension 30 (26) 82 (21) 1 (20)
Glomerulonephritis 16 (14) 83 (21) 0
Polycystic kidney disease 4 (3) 10 (3) 1 (20)‡
Others 7 (6) 25 (6) 0
Not defined 41 (36) 184 (46) 1 (20)
ESRD (yr) 3.0 (1.3–8.0) 2.0 (0–11.0) 1.0 (0.8–4.5)
Dialysis duration (month) 4.0 (1.0–24.0) 3.0 (0.5–7.0)* 1.0 (0–1.0)†
Comorbidities
Diabetes mellitus 37 (32) 86 (22)* 4 (80)†,‡
Hypertension 101 (88) 245 (62) 3 (60)
CAOD 18 (16) 9 (2)* 1 (20)‡
COPD 1 (1) 3 (1) 0
Hyperlipidemia 20 (17) 38 (10) 0
Heart failure 5 (4) 3 (1) 0
TTE, transthoracic echocardiography; ESRD, end-stage renal disease; CAOD, 
coronary artery obstructive disease; COPD, chronic obstructive pulmonary dis-
ease. 
Data are presented as mean±standard deviation, median (interquartile range), 
or n (%). 
*p<0.05 between pre- and post-transplant TTE and pre-transplant TTE group, 
†p<0.05 between pre- and post-transplant TTE and no TTE group, ‡p<0.05 be-
tween pre-transplant TTE group and no TTE group. 
Kidney transplant recipients, 2011–2015 
(n=516)
Recipients with pre- and post-echo 
(n=115)
Recipients finally analysed 
(n=97)
   Excluded (n=401) 
   - Absence of post-transplant echo (n=396)
   - No echo data (n=5)
   Excluded (n=18) 
   - Baseline systolic dysfunction (n=8)
   - Insufficient echocardiographic data (n=10)
Fig. 1. Flow diagram of patients.
294
Diastolic Function after KT
https://doi.org/10.3349/ymj.2019.60.3.291
ed with improved LV diastolic function, evidenced by de-
creased E/e’ ratio (Table 3). Moreover, eGFR at 1 year post-op-
eration continued to be an independent predictor of improved 
LV diastolic function, by means of changes in E/e’ ratio, after 
KT in multivariate analysis. Among patients with baseline dia-
stolic dysfunction,17 the amount of fluid administered during 
surgery was an independent predictor of deterioration of dia-
stolic function in terms of increase in E/e’ ratio after transplan-
tation. 
DISCUSSION
In this single-center retrospective analysis of a consecutive co-
hort of patients with ESRD who underwent KT, we showed the 
significance of post-transplantation renal function recovery on 
improvement of LV diastolic function in terms of diminution 
of E/e’ ratio. Moreover, the amount of administered intraopera-
tive fluid was independently associated with deterioration of 
LV diastolic function, elucidating the importance of intraop-
erative fluid management among patients with pre-existing 
diastolic dysfunction. 
The gold standard for assessing diastolic function is mea-
suring the mean pulmonary capillary wedge pressure and LV 
end-diastolic pressure using cardiac catheterization. Howev-
er, the invasiveness of this procedure deters it from being rou-
tinely applied to patients. Non-invasive Doppler echocardio-
graphic parameters, such as E/e’ ratio and LAVI, have also been 
used to estimate the LV filling pressure,19 showing both reli-
ability and validity for assessing diastolic function in patients 
with chronic kidney disease undergoing dialysis, as well as in 
the general population.20 Additionally, E/e’ ratio has been 
shown to be a better reflection of the mean LV end-diastolic 
pressure, a surrogate for mean LA pressure, compared to other 
Doppler parameters.21 This study focused on the significance of 
E/e’ ratio as a representative parameter of diastolic function and 
determined the relevant clinical and laboratory factors, which 
are known to influence diastolic function, that lead to proper 
patient management in patients with ESRD undergoing KT. 
Patients with chronic kidney disease show characteristic 
traits of cardiac conditions, such as left ventricular hypertrophy 
and systolic and diastolic dysfunction, all of which converge 
into the diagnosis of uremic cardiomyopathy. Such changes in 
the cardiovascular system result from physiological responses 
to pressure and volume overload, underlying electrolyte im-
balance, abnormal endocrinological conditions, and hemody-
namic alterations. Among the various cardiovascular deteriora-
tions, diastolic dysfunction is known to be a risk factor for post-
operative morbidity, and even worse, post-operative survival 
in patients undergoing surgery. Such patients need more ap-
propriate anesthetic management in order to prevent post-op-
erative complications. Despite this significance, diastolic dys-
function is still overlooked in cardiac risk evaluation, because it 
is not usually a significant problem in the daily life of patients 
who do not suffer from exercise intolerance, dyspnea, or pul-
monary edema.22 The American Heart Association-American 
College of Cardiology guidelines23 indicate that diastolic dys-
function is still underestimated in pre-operative risk assessment. 
In a previous study, pre-operative diastolic function showed pre-
dictive power for post-operative outcomes in patients under-
going KT.11 Therefore, this retrospective cohort study of patients 
undergoing KT was conducted to identify the perioperative 
clinical and laboratory factors related to aggravation of diastol-
ic dysfunction, thereby emphasizing the need for ideal periop-
Table 2. Post-Transplantation Outcomes
Variable Pre-transplant Post-transplant p value
LVEF (%) 66.4±5.8 68.2±5.5 0.037
LV mass/body surface area 
(g/m2)
All patients 129.4±34.6 108.7±33.4 <0.001
Baseline LV hypertrophy 
(n=78)
138.6±31.6 111.8±35.5 <0.001
LV end-diastolic diameter (cm)
All patients 5.2±0.5 4.8±0.4 <0.001
Baseline ≥5.6 (n=18) 5.9±0.2 5.0±0.5 <0.001
LA volume index (mL/m2)
All patients 33.8±11.1 29.2±8.5 0.002
Baseline, mild ≥35 (n=42) 44.0±7.6 33.2±8.7 <0.001
Baseline, moderate ≥42 
(n=22) 
49.3±6.9 34.7±8.7 <0.001
E/e’ ratio 
All patients 11.9±4.4 10.5±3.8 0.023
Diastolic dysfunction 
(n=20)
18.4±3.7 12.1±4.7 <0.001
RV systolic pressure (mm Hg)
All patients 27.8±9.3 26.2±6.7 0.191
Baseline ≥40 (n=10) 48.0±6.1 29.1±7.7 <0.001
Mean blood pressure 
(mm Hg)
All patients 111.0±11.9 107.8±15.7 0.103
Hemoglobin (g/dL)
All patients 10.1±1.7 11.2±1.1 <0.001
Baseline anemia (n=92) 10.0±1.6 11.2±1.0 <0.001
eGFR pre-transplant 9.0±3.7
Post-operative day 1 21.1±11.0 <0.001
Post-operative day 2 53.1±27.1 <0.001
Post-operative day 7 64.1±28.8 <0.001
Post-operative 1 yr 61.7±20.9 <0.001
Mortality 2 (2)
Major adverse 
cardiovascular event
14 (14)
Graft failure 10 (10)
Acute rejection 20 (21)
LVEF, left ventricular ejection fraction; LV, left ventricular; LA, left atrial; RV, 
right ventricular; eGFR, estimated glomerular filtration rate; ACE, angiotensin-
converting enzyme; ARB, angiotensin II receptor blocker.
Data are presented as mean±standard deviation or n (%).
295
Eun Jung Kim, et al.
https://doi.org/10.3349/ymj.2019.60.3.291
erative management of patients with ESRD during KT. Patients 
with pre-existing LV systolic dysfunction were excluded to rule 
out the effects of systolic function on clinical outcomes.
In this study, we observed a significant relationship between 
the restoration of renal function and cardiac reverse remodel-
ing after KT in terms of LV mass, LV end-diastolic dimension, 
LA volume, right ventricular systolic pressure, and E/e’ ratio. 
Nevertheless, the majority of patients with ESRD, who are likely 
to suffer from pre-existing LV diastolic dysfunction (e.g., ele-
vated E/e’ ratio), exhibit different reactions in diastolic func-
tion, compared to other individuals with normal cardiac func-
tion during the perioperative period. Therefore, when discretely 
analyzed, the amount of fluid administered intraoperatively 
was identified to be associated with the changes in diastolic 
function after surgery. In other words, LV diastolic function im-
proved as patient renal function recovered after transplanta-
tion, but deteriorated when given a greater amount of fluid 
during surgery, especially in patients with underlying diastolic 
dysfunction. Such findings are consistent with previous studies 
stating the impact of renal function and hemodynamic volume 
status on LV diastolic function in patients with ESRD.22,24,25 Our 
findings also coincide with the vulnerability of diastolic dys-
function on massive and acute fluid challenge during transplan-
tation surgery, which is the type of surgery that is accompanied 
by extensive amounts of fluid administration over a relatively 
short period, and consequently aggravates diastolic function 
due to inadequate compensation. 
In pursuit of understanding the significance of fluid manage-
ment strategy during the post-operative period, a secondary 
statistical analysis of the relationship between changes in E/e’ 
ratio and the amount of fluid administered during the post-op-
erative period was conducted. As a result, there was no signifi-
cant impact of the amount of fluid given at post-operative days 
1, 2, and 7 on alterations in cardiac function in terms of chang-
es in measured E/e’ ratio (Table 3). However, our study suc-
ceeded in showing the significance of both intraoperative vol-
ume management and the vulnerability of the cardiovascular 
system on volume changes in patients with ESRD undergoing 
KT, which consequently clarified the specific efforts needed for 
such patients during renal transplantation surgery in an effort 
to protect perioperative cardiovascular function. 
Our study had several limitations. First, this was a single-
center retrospective study evaluating a small number of pa-
tients. Specifically, we investigated evaluable patients who sur-
vived during the perioperative period to allow both pre- and 
post-operative TTE, and the possibility of selection bias might 
have influenced the results. Second, different time intervals 
for follow-up TTEs need to be considered. Echocardiograms 
were done at different time intervals after surgery based upon 
clinical need, instead of being performed at designated times. 
Table 3. Analysis of Univariate and Multivariate Linear Regression: Predictors of Changes in Left Ventricular Diastolic Function after Kidney Trans-
plantation 
ΔE/e’ ratio 
(all patients, n=97)
ΔE/e’ ratio 
(patients with diastolic dysfunction, 
n=20)
Univariate coefficient 
(95% CI)
p value
Multivariate coefficient 
(95% CI)
p value
Univariate coefficient 
(95% CI)
p value
Transplant age 0.005 (-0.078 to 0.089) 0.898 0.169 (-0.149 to 0.488) 0.278
Body mass index 0.192 (-0.116 to 0.501) 0.219 -0.057 (-0.741 to 0.626) 0.862
Male -0.063 (-1.936 to 1.811) 0.947 -1.128 (-6.067 to 3.811) 0.637
Dialysis duration 0.015 (-0.008 to 0.039) 0.193 0.029 (-0.037 to 0.095) 0.367
ΔMean blood pressure 0.024 (-0.030 to 0.078) 0.378 0.077 (-0.142 to 0.296) 0.470
ΔeGFR, post-operative day 1 0.065 (-0.025 to 0.155) 0.154 0.195 (-0.074 to 0.463) 0.142
ΔeGFR, post-operative day 2 -0.011 (-0.046 to 0.023) 0.510 -0.007 (-0.164 to 0.151) 0.931
ΔeGFR, post-operative day 7 -0.033 (-0.065 to -0.002) 0.040       -0.011 (-0.047–0.025) 0.537 -0.055 (-0.150 to 0.041) 0.247
ΔeGFR, post-operative 1 yr -0.063 (-0.105 to -0.021) 0.004       -0.056 (-0.104–-0.007) 0.026 -0.054 (-0.186 to 0.078) 0.398
ΔHemoglobin -0.418 (-0.888 to -0.053) 0.081 -1.048 (-2.332 to 0.237) 0.104
Intraoperative Input/output
Fluid 0.000 (-0.001 to 0.001) 0.964 0.003 (0.000 to 0.005) 0.029
Transfusion 0.000 (-0.003 to 0.002) 0.746 0 (-0.006 to 0.006) 0.968
Urine Output 0.001 (-0.001 to 0.003) 0.228 0.002 (-0.003 to 0.007) 0.432
Blood loss -0.003 (-0.006 to 0.000) 0.072 0 (-0.008 to 0.008) 0.954
Fluid, post-operative day 1 0 (-0.001 to 0.000) 0.121 -0.001 (-0.001 to 0.000) 0.201
Fluid, post-operative day 2 0 (-0.001 to 0.000) 0.065 -0.001 (-0.002 to 0.000) 0.208
Fluid, post-operative day 7 0 (-0.001 to 0.001) 0.691 -0.002 (-0.004 to 0.001) 0.118
Operation time -0.010 (-0.025 to 0.004) 0.169 0.032 (-0.025 to 0.089) 0.253
CI, confidence interval; eGFR, estimated glomerular filtration rate.
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This limited our ability to properly evaluate changes in dia-
stolic function over a fixed period. Thus, further studies using 
regular follow-up post-operative TTEs should be considered 
for more detailed interpretations on changes in diastolic func-
tion after KT in patients with ESRD. Moreover, as some of our 
enrolled patients had been scheduled for preemptive KT be-
fore full-blown kidney failure, such patient characteristics may 
have affected the perioperative outcomes, including cardiac 
functions. Although our results indicated a significant relation-
ship reflective of how intraoperative LV loading condition can 
affect postoperative diastolic performance, more extensive 
and in-depth study is needed for thorough explanation of the 
influence of occult volume overload in KT, altered physiology 
of vascular endothelium and degraded diastolic function of 
heart. Lastly, the inherent limitations in echocardiographic meth-
ods used to quantify diastolic function need to be considered. 
However, although other means of assessment, such as cardiac 
magnetic resonance, are considered as the “gold standard” for 
evaluating cardiac structure and function, echocardiography 
remains an important clinical and research tool when consid-
ering its availability and practicality. 
In conclusion, this study reported a significant relationship 
between post-operative renal function and changes in LV dia-
stolic function after renal transplantation surgery in patients 
with ESRD. Additionally, the significance of intraoperative flu-
id management on changes in LV diastolic function, especial-
ly in patients with pre-existing diastolic dysfunction prior to 
surgery, was observed. Despite the limitations, this study suc-
ceeded in identifying the important transition of LV diastolic 
function of patients with ESRD after KT and also supported 
the establishment of definite guidelines for intra- and post-op-
erative management plans for such patients. LV diastolic dys-
function is an independent risk factor for post-operative major 
adverse cardiovascular events and mortality after transplanta-
tion. Therefore, optimal intraoperative fluid management may 
reduce the risk of worsening diastolic dysfunction and improve 
post-KT renal function in patients with pretexting diastolic dys-
function.
ACKNOWLEDGEMENTS
This study was supported by a new faculty research seed money 
grant of Yonsei University College of Medicine for 2017 (2017-
32-0027).
AUTHOR CONTRIBUTIONS
Conceptualization: Eun Jung Kim, So Yeon Kim, and Yong Seon Choi. 
Data curation: Eun Jung Kim, So Yeon Kim, and Soojeong Kang. For-
mal analysis: Eun Jung Kim, Soojeong Kang, and Yong Seon Choi. 
Funding acquisition: Eun Jung Kim. Investigation: Eun Jung Kim, 
Bon-Nyeo Koo, Kyu Ha Huh, and Yong Seon Choi. Methodology: Eun 
Jung Kim and Yong Seon Choi. Project administration: Eun Jung Kim, 
Bon-Nyeo Koo, Kyu Ha Huh, and Yong Seon Choi. Resources: Eun 
Jung Kim, Kyu Ha Huh, Soojeong Kang, and Yong Seon Choi. Soft-
ware: Eun Jung Kim and Yong Seon Choi. Supervision: Bon-Nyeo 
Koo and Yong Seon Choi. Validation: Bon-Nyeo Koo and Yong Seon 
Choi. Visualization: Eun Jung Kim. Writing—original draft: Eun Jung 
Kim. Writing—review & editing: Bon-Nyeo Koo, So Yeon Kim, Kyu Ha 
Huh, Soojeong Kang, and Yong Seon Choi.
ORCID iDs
Eun Jung Kim http://orcid.org/0000-0002-5693-1336
Bon-Nyeo Koo https://orcid.org/0000-0002-3189-1673
So Yeon Kim https://orcid.org/0000-0001-5352-157X
Kyu Ha Huh https://orcid.org/0000-0003-1364-6989
Soojeong Kang https://orcid.org/0000-0003-1778-4457
Yong Seon Choi https://orcid.org/0000-0002-5348-864X
REFERENCES
1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Cher-
tow GM. Mineral metabolism, mortality, and morbidity in main-
tenance hemodialysis. J Am Soc Nephrol 2004;15:2208-18.
2. Pecoits-Filho R, Bucharles S, Barberato SH. Diastolic heart failure 
in dialysis patients: mechanisms, diagnostic approach, and treat-
ment. Semin Dial 2012;25:35-41. 
3. Losi MA, Memoli B, Contaldi C, Barbati G, Del Prete M, Betocchi S, 
et al. Myocardial fibrosis and diastolic dysfunction in patients on 
chronic haemodialysis. Nephrol Dial Transplant 2010;25:1950-4.
4. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass 
in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009;4 
Suppl 1:S79-91.
5. Hawwa N, Shrestha K, Hammadah M, Yeo PSD, Fatica R, Tang 
WHW. Reverse remodeling and prognosis following kidney trans-
plantation in contemporary patients with cardiac dysfunction. J 
Am Coll Cardiol 2015;66:1779-87.
6. Ferreira SR, Moisés VA, Tavares A, Pacheco-Silva A. Cardiovascu-
lar effects of successful renal transplantation: a 1-year sequential 
study of left ventricular morphology and function, and 24-hour 
blood pressure profile. Transplantation 2002;74:1580-7.
7. Hewing B, Dehn AM, Staeck O, Knebel F, Spethmann S, Stangl K, et 
al. Improved left ventricular structure and function after successful 
kidney transplantation. Kidney Blood Press Res 2016;41:701-9. 
8. Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos 
E, et al. Effect of kidney transplantation on left ventricular systolic 
dysfunction and congestive heart failure in patients with end-stage 
renal disease. J Am Coll Cardiol 2005;45:1051-60.
9. Sharma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, Streather 
CP, et al. Mitral peak Doppler E-wave to peak mitral annulus ve-
locity ratio is an accurate estimate of left ventricular filling pres-
sure and predicts mortality in end-stage renal disease. J Am Soc 
Echocardiogr 2006;19:266-73.
10. Higashi M, Yamaura K, Ikeda M, Shimauchi T, Saiki H, Hoka S. Di-
astolic dysfunction of the left ventricle is associated with pulmonary 
edema after renal transplantation. Acta Anaesthesiol Scand 2013; 
57:1154-60. 
11. Kim EJ, Chang S, Kim SY, Huh KH, Kang S, Choi YS. Predictive value 
of echocardiographic abnormalities and the impact of diastolic 
dysfunction on in-hospital major cardiovascular complications after 
living donor kidney transplantation. Int J Med Sci 2016;13:620-8. 
12. El-Husseini AA, Sheashaa HA, Hassan NA, El-Demerdash FM, 
Sobh MA, Ghoneim MA. Echocardiographic changes and risk fac-
tors for left ventricular hypertrophy in children and adolescents 
after renal transplantation. Pediatr Transplant 2004;8:249-54.
297
Eun Jung Kim, et al.
https://doi.org/10.3349/ymj.2019.60.3.291
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more 
accurate method to estimate glomerular filtration rate from serum 
creatinine: a new prediction equation. Modification of Diet in Re-
nal Disease Study Group. Ann Intern Med 1999;130:461-70.
14. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia 
Work Group. KDIGO Clinical Practice Guideline for anemia in 
chronic kidney disease. Kidney Int Suppl 2012;2:279-335.
15. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assess-
ment of mitral annulus velocity by Doppler tissue imaging in the 
evaluation of left ventricular diastolic function. J Am Coll Cardiol 
1997;30:474-80.
16. Kim YJ, Sohn DW. Mitral annulus velocity in the estimation of left 
ventricular filling pressure: prospective study in 200 patients. J Am 
Soc Echocardiogr 2000;13:980-5.
17. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, 
Edvardsen T, et al. Recommendations for the evaluation of left 
ventricular diastolic function by echocardiography: an update 
from the American Society of Echocardiography and the Europe-
an Association of Cardiovascular Imaging. J Am Soc Echocardiogr 
2016;29:277-314. 
18. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, 
et al. Recommendations for cardiac chamber quantification by 
echocardiography in adults: an update from the American Society 
of Echocardiography and the European Association of Cardiovas-
cular Imaging. J Am Soc Echocardiogr 2015;28:1-39.
19. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. 
Doppler tissue imaging: a noninvasive technique for evaluation of 
left ventricular relaxation and estimation of filling pressures. J Am 
Coll Cardiol 1997;30:1527-33.
20. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Red-
field MM, et al. Clinical utility of Doppler echocardiography and 
tissue Doppler imaging in the estimation of left ventricular filling 
pressures: a comparative simultaneous Doppler-catheterization 
study. Circulation 2000;102:1788-94.
21. Hayashi SY, Rohani M, Lindholm B, Brodin LA, Lind B, Barany P, 
et al. Left ventricular function in patients with chronic kidney dis-
ease evaluated by colour tissue Doppler velocity imaging. Nephrol 
Dial Transplant 2006;21:125-32.
22. Ryu T, Song SY. Perioperative management of left ventricular dia-
stolic dysfunction and heart failure: an anesthesiologist’s perspec-
tive. Korean J Anesthesiol 2017;70:3-12.
23. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beck-
man JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative 
cardiovascular evaluation and management of patients undergo-
ing noncardiac surgery: a report of the American College of Cardi-
ology/American Heart Association Task Force on practice guide-
lines. J Am Coll Cardiol 2014;64:e77-137. 
24. Ybarra J, Sánchez-Hernández J, Vilallonga R, Romeo JH. Differen-
tial associations between glomerular filtration rate and duration of 
obesity depending on the presence or absence of left ventricular 
diastolic dysfunction. Eur J Intern Med 2016;32:47-52. 
25. Calleja AM, Rakowski H, Williams LK, Jamorski M, Chan CT, 
Carasso S. Left atrial and ventricular systolic and diastolic myocar-
dial mechanics in patients with end-stage renal disease. Echocar-
diography 2016;33:1495-503.
